Sinopharm Medical - B (06669.HK) announced that it has received registration approval from the China National Medical Products Administration for the disposable catheter sheath set Acotrace. The company will timely carry out marketing activities in the mainland. Acotrace is suitable for percutaneous puncture in interventional surgery, used to insert guide wires, and catheter-type medical instruments into blood vessels.
先瑞達醫療(06669.HK)一次性導管鞘組Acotrace註冊申請獲批
Acorus Medical (06669.HK) has received regulatory approval for the registration of the single-use Cath-Kit™ Acotrace.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha